TUESDAY DEADLINE: Talis Biomedical Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – TLIS
- Sunday, March 6, 2022, 7:18
- PR Newswire
- Add a comment
SAN DIEGO, March 5, 2022 /PRNewswire/ — Robbins Geller Rudman & Dowd LLP announces that purchasers of Talis Biomedical Corporation (NASDAQ: TLIS) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in…
About the Author
admin has written 21793 stories on this site.